IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-023-03971-5
E
Eleonora Cioli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
80
Citations
5
h-index
5
i10-index
Eleonora Cioli is an academic researcher from University of Campania "Luigi Vanvitelli". The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways. The author has an h-index of 5, co-authored 20 publications.
ORCID: 0000-0002-8788-6574Papers by this author
worksBRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives
2025 · Cancer Treatment Reviews · 11 citations
https://doi.org/10.1016/j.ctrv.2025.102905
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
2025 · ESMO Open · 11 citations
https://doi.org/10.1016/j.esmoop.2025.104511
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned
2023 · Current Oncology Reports · 10 citations
https://doi.org/10.1007/s11912-023-01402-8
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
2024 · Cancer Immunology Immunotherapy · 9 citations
https://doi.org/10.1007/s00262-024-03728-z
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
2025 · ESMO Real World Data and Digital Oncology · 1 citations
https://doi.org/10.1016/j.esmorw.2024.100108
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat